Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 4:53 pm Unchanged |
2025-03-05 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 351,071 8.800% |
0 (Unchanged) |
Filing History |
| 2025-01-15 4:14 pm Purchase |
2025-01-08 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 351,071 10.300% |
116,278 (+49.52%) |
Filing History |
| 2024-12-17 4:22 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
Dellora Investments Master Fund LP | 141,079 1.300% |
141,079 (New Position) |
Filing History |
| 2024-12-06 2:21 pm Purchase |
2024-11-06 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 141,079 10.700% |
32,105 (+29.46%) |
Filing History |
| 2024-12-05 1:47 pm Purchase |
2024-11-27 | 13G | Tenax Therapeutics, Inc. TENX |
Dellora Investments Master Fund LP | 234,793 6.900% |
234,793 (New Position) |
Filing History |
| 2024-08-07 2:16 pm Purchase |
2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Dellora Investments Master Fund LP | 108,974 8.300% |
108,974 (New Position) |
Filing History |
| 2024-02-14 10:09 am Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 0 0.000% |
-43,250 (Position Closed) |
Filing History |
| 2023-02-13 4:16 pm Unchanged |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 43,250 5.200% |
0 (Unchanged) |
Filing History |
| 2022-08-22 1:17 pm Purchase |
2022-08-11 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Dellora Investments Master Fund LP | 43,250 5.200% |
43,250 (New Position) |
Filing History |